Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Symptoms and risk factors for hospitalization of COVID-19 presented in primary care : An exploratory retrospective study.
Rabady S, Hoffmann K, Brose M, Lammel O, Poggenburg S, Redlberger-Fritz M, Stiasny K, Wendler M, Weseslindtner L, Zehetmayer S, Kamenski G. Rabady S, et al. Among authors: brose m. Wien Klin Wochenschr. 2022 May;134(9-10):335-343. doi: 10.1007/s00508-021-01992-y. Epub 2022 Feb 11. Wien Klin Wochenschr. 2022. PMID: 35149931 Free PMC article.
[Guideline S1: Long COVID: Diagnostics and treatment strategies].
Rabady S, Altenberger J, Brose M, Denk-Linnert DM, Fertl E, Götzinger F, de la Cruz Gomez Pellin M, Hofbaur B, Hoffmann K, Hoffmann-Dorninger R, Koczulla R, Lammel O, Lamprecht B, Löffler-Ragg J, Müller CA, Poggenburg S, Rittmannsberger H, Sator P, Strenger V, Vonbank K, Wancata J, Weber T, Weber J, Weiss G, Wendler M, Zwick RH. Rabady S, et al. Among authors: brose m. Wien Klin Wochenschr. 2021 Dec;133(Suppl 7):237-278. doi: 10.1007/s00508-021-01974-0. Epub 2021 Dec 1. Wien Klin Wochenschr. 2021. PMID: 34851455 Free PMC article. German.
[S1 guidelines for the management of postviral conditions using the example of post-COVID-19].
Rabady S, Hoffmann K, Aigner M, Altenberger J, Brose M, Costa U, Denk-Linnert DM, Gruber S, Götzinger F, Helbok R, Hüfner K, Koczulla R, Kurz K, Lamprecht B, Leis S, Löffler J, Müller CA, Rittmannsberger H, Rommer PS, Sator P, Strenger V, Struhal W, Untersmayr E, Vonbank K, Wancata J, Weber T, Wendler M, Zwick RH. Rabady S, et al. Among authors: brose m. Wien Klin Wochenschr. 2023 Jul;135(Suppl 4):525-598. doi: 10.1007/s00508-023-02242-z. Epub 2023 Aug 9. Wien Klin Wochenschr. 2023. PMID: 37555900 Free PMC article. German.
Efficacy and Safety of a Tetravalent Dengue Vaccine (TAK-003) in Children With Prior Japanese Encephalitis or Yellow Fever Vaccination.
Sirivichayakul C, Biswal S, Saez-Llorens X, López-Medina E, Borja-Tabora C, Bravo L, Kosalaraksa P, Alera MT, Reynales H, Rivera L, Watanaveeradej V, Yu D, Espinoza F, Dietze R, Fernando L, Wickramasinghe VP, Moreira ED Jr, Fernando AD, Gunasekera D, Luz K, Venâncio da Cunha R, Oliveira AL, Rauscher M, Fan H, Borkowski A, Escudero I, Tuboi S, Lloyd E, Tricou V, Folschweiller N, LeFevre I, Vargas LM, Wallace D; TIDES Study Group. Sirivichayakul C, et al. J Infect Dis. 2024 Apr 29:jiae222. doi: 10.1093/infdis/jiae222. Online ahead of print. J Infect Dis. 2024. PMID: 38682569
Proposal and practicality of an alternative blue-light hazard risk assessment method for high-intensity white-light sources at workplaces.
Bauer S, Berget M, Borra M, Brissinger D, Brose M, Görlich S, Halbritter W, Heepenstrick T, Janßen M, Kitz E, Kubica JM, Łowcewicz M, Marro M, Militello A, Pelko M, Rybczyński A, Weber M, Wolska A. Bauer S, et al. Among authors: brose m. Int J Occup Saf Ergon. 2024 Jun;30(2):450-459. doi: 10.1080/10803548.2024.2317050. Epub 2024 Apr 4. Int J Occup Saf Ergon. 2024. PMID: 38378446
Natural reversion promotes LPS elongation in an attenuated Coxiella burnetii strain.
Long CM, Beare PA, Cockrell D, Binette P, Tesfamariam M, Richards C, Anderson M, McCormick-Ell J, Brose M, Anderson R, Omsland A, Pearson T, Heinzen RA. Long CM, et al. Among authors: brose m. Nat Commun. 2024 Jan 24;15(1):697. doi: 10.1038/s41467-023-43972-y. Nat Commun. 2024. PMID: 38267444 Free PMC article.
Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146.
Makker V, Taylor MH, Aghajanian C, Cohn AL, Brose MS, Simone CD, Cao ZA, Suttner L, Loboda A, Cristescu R, Jelinic P, Orlowski R, Dutta L, Matsui J, Dutcus CE, Minoshima Y, Messing MJ. Makker V, et al. Among authors: brose ms. J Immunother Cancer. 2024 Jan 19;12(1):e007929. doi: 10.1136/jitc-2023-007929. J Immunother Cancer. 2024. PMID: 38242717 Free PMC article.
Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 Study.
Capdevila J, Krajewska J, Hernando J, Robinson B, Sherman SI, Jarzab B, Lin CC, Vaisman F, Hoff AO, Hitre E, Bowles DW, Williamson D, Levytskyy R, Oliver J, Keam B, Brose MS. Capdevila J, et al. Among authors: brose ms. Thyroid. 2024 Mar;34(3):347-359. doi: 10.1089/thy.2023.0463. Epub 2024 Jan 23. Thyroid. 2024. PMID: 38062732 Free PMC article. Clinical Trial.
145 results